Lineage Cell Therapeutics: Q4 Earnings Insights
Lineage Cell Therapeutics: Q4 Earnings Insights
Lineage Cell Therapeutics (AMEX:LCTX) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:01 PM.
Lineage Cell Therapeutics（美国证券交易所股票代码：LCTX）于2024年3月7日星期四下午4点01分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Lineage Cell Therapeutics beat estimated earnings by 25.0%, reporting an EPS of $-0.03 versus an estimate of $-0.04.
Lineage Cell Therapeutics的收益比预期高出25.0％，每股收益为-0.03美元，而估计为-0.04美元。
Revenue was up $200 thousand from the same period last year.
收入比去年同期增长了20万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company missed on EPS by $0.0 which was followed by a 3.0% drop in the share price the next day.
上个季度，该公司的每股收益下跌了0.0美元，随后第二天股价下跌了3.0％。
Here's a look at Lineage Cell Therapeutics's past performance:
以下是Lineage Cell Therapeutics过去的表现：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.04 | -0.04 | -0.04 | -0.04 |
| EPS Actual | -0.04 | -0.03 | -0.03 | -0.03 |
| Revenue Estimate | 2.59M | 2.20M | 2.01M | 2.57M |
| Revenue Actual | 1.25M | 3.23M | 2.39M | 1.90M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.04 | -0.04 | -0.04 | -0.04 |
| 实际每股收益 | -0.04 | -0.03 | -0.03 | -0.03 |
| 收入估算 | 2.59 亿 | 2.20M | 2.01M | 2.57M |
| 实际收入 | 1.25 米 | 3.23 M | 2.39 M | 1.90 米 |
To track all earnings releases for Lineage Cell Therapeutics visit their earnings calendar here.
要追踪Lineage Cell Therapeutics发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。